Loading company…
TionLab Therapeutics develops long-acting injections and drug delivery technologies.
Founded in 2021 and based in Yongin, South Korea, TionLab Therapeutics develops long-acting injections and drug delivery technologies. Its platforms include lipid nanoparticles for delivering chemicals, peptides, and RNA therapeutics, and biodegradable microspheres. The company is also developing a drug for its next-generation delivery platform. In July 2023, it raised venture funding from Series Ventures to advance its Quject platform technology. Duck-soo Lim was CEO as of July 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in